{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T18:36:37Z","timestamp":1778006197043,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T00:00:00Z","timestamp":1643846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T00:00:00Z","timestamp":1643846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s00467-022-05449-w","type":"journal-article","created":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T22:03:26Z","timestamp":1643925806000},"page":"2179-2183","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of the relationship between serum carnitine levels and intradialytic complications in children with kidney failure"],"prefix":"10.1007","volume":"37","author":[{"given":"Behnaz","family":"Bazargani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayed Yousef","family":"Mojtahedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daryoosh","family":"Fahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahimeh","family":"Askarian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mastaneh","family":"Moghtaderi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arash","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Samimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3067-0307","authenticated-orcid":false,"given":"Maryam","family":"Bakhtiari Koohsorkhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,3]]},"reference":[{"key":"5449_CR1","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1099\/mic.0.000080","volume":"161","author":"JA Meadows","year":"2015","unstructured":"Meadows JA, Wargo MJ (2015) Carnitine in bacterial physiology and metabolism. Microbiology (Reading) 161:1161\u20131174","journal-title":"Microbiology (Reading)"},{"key":"5449_CR2","first-page":"36","volume":"10","author":"M Naseri","year":"2016","unstructured":"Naseri M, Mottaghi Moghadam Shahri H, Horri M, Esmaeeli M, Ghaneh Sherbaf F, Jahanshahi S et al (2016) Absolute and relative carnitine deficiency in patients on hemodialysis and peritoneal dialysis. Iran J Kidney Dis 10:36\u201343","journal-title":"Iran J Kidney Dis"},{"key":"5449_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013601","author":"N Nishioka","year":"2020","unstructured":"Nishioka N, Luo Y, Taniguchi T, Ohnishi T, Kimachi M, Ng RC et al (2020) Carnitine supplements for people with chronic kidney disease requiring dialysis. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD013601","journal-title":"Cochrane Database Syst Rev"},{"key":"5449_CR4","doi-asserted-by":"crossref","unstructured":"Reuter SE, Faull RJ, Evans AM (2008) L-carnitine supplementation in the dialysis population: are Australian patients missing out? Nephrology (Carlton)13:3\u201316","DOI":"10.1111\/j.1440-1797.2007.00817.x"},{"key":"5449_CR5","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1053\/j.jrn.2014.10.025","volume":"25","author":"G Guarnieri","year":"2015","unstructured":"Guarnieri G (2015) Carnitine in maintenance hemodialysis patients. J Ren Nutr 25:169\u2013175","journal-title":"J Ren Nutr"},{"key":"5449_CR6","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s00467-005-2085-4","volume":"21","author":"B Belay","year":"2005","unstructured":"Belay B, Esteban-Cruciani N, Walsh C, Kaskel F (2005) The use of levo-carnitine in children with renal disease: a review and a call for future studies. Pediatr Nephrol 21:308\u2013317","journal-title":"Pediatr Nephrol"},{"key":"5449_CR7","first-page":"60","volume":"6","author":"A Sabry","year":"2009","unstructured":"Sabry A, Ghaith O, Medhat T, George SK, Elshafey EM (2009) Is there a role for oral L-carnitine therapy in anemia and cardiac dysfunction management in Egyptian patients on maintenance hemodialysis? Eur J Gen Med 6:60\u201368","journal-title":"Eur J Gen Med"},{"key":"5449_CR8","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00467-009-1276-9","volume":"25","author":"B Aoun","year":"2010","unstructured":"Aoun B, B\u00e9rard E, Vitkevic R, Deh\u00e9e A, Bensman A, Ulinski T (2010) L-carnitine supplementation and EPO requirement in children on chronic hemodialysis. Pediatr Nephrol 25:557\u2013560","journal-title":"Pediatr Nephrol"},{"key":"5449_CR9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1750-1172-7-68","volume":"7","author":"PL Magoulas","year":"2012","unstructured":"Magoulas PL, El-Hattab AW (2012) Systemic primary carnitine deficiency: an overview of clinical manifestations, diagnosis, and management. Orphanet J Rare Dis 7:68","journal-title":"Orphanet J Rare Dis"},{"key":"5449_CR10","doi-asserted-by":"publisher","first-page":"862","DOI":"10.5812\/numonthly.10670","volume":"5","author":"H Tayebi Khosroshahi","year":"2013","unstructured":"Tayebi Khosroshahi H, Habibi Asl B, Habibzadeh A, Chaichi P, Ghanbarpour A, Hossein Badie A (2013) Comparison of vitamin E and L-carnitine, separately or in combination in patients with intradialytic complications. Nephrourol Mon 5:862\u2013865","journal-title":"Nephrourol Mon"},{"key":"5449_CR11","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.3390\/nu13041219","volume":"13","author":"H Takashima","year":"2021","unstructured":"Takashima H, Maruyama T, Abe M (2021) Significance of levocarnitine treatment in dialysis patients. Nutrients 13:1219","journal-title":"Nutrients"},{"key":"5449_CR12","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1053\/j.ajkd.2015.09.010","volume":"67","author":"T Higuchi","year":"2016","unstructured":"Higuchi T, Abe M, Yamazaki T, Okawa E, Ando H, Hotta S et al (2016) Levocarnitine improves cardiac function in hemodialysis patients with left ventricular hypertrophy: a randomized controlled trial. Am J Kidney Dis 67:260\u2013270","journal-title":"Am J Kidney Dis"},{"key":"5449_CR13","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1046\/j.1442-200X.2002.01498.x","volume":"44","author":"S Mir","year":"2002","unstructured":"Mir S, Kantar M, Yalaz M, Keskinoglu A, Coker I, Huseyinov A (2002) Effect of hemodialysis on carnitine levels in children with chronic renal failure. Pediatr Int 44:70\u201373","journal-title":"Pediatr Int"},{"key":"5449_CR14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/1744-9987.12553","volume":"21","author":"HR Ibarra-Sifuentes","year":"2017","unstructured":"Ibarra-Sifuentes HR, Del Cueto-Aguilera \u00c1, Gallegos-Arguijo DA, Castillo-Torres SA, Vera-Pineda R, Mart\u00ednez-Granados RJ et al (2017) Levocarnitine decreases intradialytic hypotension episodes: a randomized controlled trial. Ther Apher Dial 21:459\u2013464","journal-title":"Ther Apher Dial"},{"key":"5449_CR15","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.3390\/nu11112645","volume":"11","author":"S Shimizu","year":"2019","unstructured":"Shimizu S, Takashima H, Tei R, Furukawa T, Okamura M, Kitai M et al (2019) Prevalence of carnitine deficiency and decreased carnitine levels in patients on peritoneal dialysis. Nutrients 11:2645","journal-title":"Nutrients"},{"key":"5449_CR16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1159\/000496720","volume":"47","author":"Y Hatanaka","year":"2019","unstructured":"Hatanaka Y, Higuchi T, Akiya Y, Horikami T, Tei R, Furukawa T et al (2019) Prevalence of carnitine deficiency and decreased carnitine levels in patients on hemodialysis. Blood Purif 47:38\u201344","journal-title":"Blood Purif"},{"key":"5449_CR17","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1080\/0886022X.2016.1229967","volume":"38","author":"Y-m Zhang","year":"2016","unstructured":"Zhang Y-m, Zhuo L, Hu J, Cui G, Zhang L, Zhang X et al (2016) Clinical significance of different carnitine levels for improving the prognosis of patients undergoing hemodialysis. Ren Fail 38:1654\u20131658","journal-title":"Ren Fail"},{"key":"5449_CR18","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.3390\/nu12113371","volume":"12","author":"M Kuwasawa-Iwasaki","year":"2020","unstructured":"Kuwasawa-Iwasaki M, Io H, Muto M, Ichikawa S, Wakabayashi K, Kanda R et al (2020) Effects of L-carnitine supplementation in patients receiving hemodialysis or peritoneal dialysis. Nutrients 12:3371","journal-title":"Nutrients"},{"key":"5449_CR19","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1159\/000355016","volume":"3","author":"Y Kudoh","year":"2013","unstructured":"Kudoh Y, Aoyama S, Torii T, Chen Q, Nagahara D, Sakata H et al (2013) Hemodynamic stabilizing effects of L-carnitine in chronic hemodialysis patients. Cardiorenal Med 3:200\u2013207","journal-title":"Cardiorenal Med"},{"key":"5449_CR20","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1007\/s00467-021-05080-1","volume":"36","author":"F Hamedi-Kalajahi","year":"2021","unstructured":"Hamedi-Kalajahi F, Zarezadeh M, Mojtahedi SY, Shabbidar S, Fahimi D, Imani H (2021) Effect of L-carnitine supplementation on lipid profile and apolipoproteins in children on hemodialysis: a randomized placebo-controlled clinical trial. Pediatr Nephrol 36:3741\u20133747","journal-title":"Pediatr Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-022-05449-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-022-05449-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-022-05449-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T22:43:45Z","timestamp":1700174625000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-022-05449-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,3]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["5449"],"URL":"https:\/\/doi.org\/10.1007\/s00467-022-05449-w","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,3]]},"assertion":[{"value":"7 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}